AUTOANTIGEN RNA HELICASE II/GU
自身抗原 RNA 解旋酶 II/GU
基本信息
- 批准号:6381322
- 负责人:
- 金额:$ 18.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:RNA biosynthesis RNase protection assay Xenopus oocyte autoantigens binding sites chemical kinetics double stranded RNA enzyme activity enzyme mechanism enzyme structure enzyme substrate expression cloning genetic transcription guanosine triphosphate helicase northern blottings nucleic acid structure nucleolus posttranscriptional RNA processing ribosomal RNA site directed mutagenesis
项目摘要
A cDNA that codes for a nucleolar RNA helicase has recently been cloned in our laboratory using an autoimmune serum from a patient with watermelon stomach disease. Later studies in our laboratory show that this autoantibody is also present in some patients with connective tissue diseases. This 100-kDa autoantigen, referred to as RH-II/Gu protein, is a unique bifunctional enzyme which possesses a 5' to 3' ATP-dependent RNA unwinding activity and a GTP-stimulated RNA folding/annealing activity. The two activities are oppositely regulated and reside in separate domains of the same polypeptide. This is the first mammalian prototype nucleolar RNA helicase to be identified. Electron microscopy shows its localization to nucleolar structures associated with transcription, early processing and maturation of rRNA. It is hypothesized that RH-II/Gu is involved in rDNA transcription, binding and/or unwinding of small nucleolar RNAs which direct site-specific cleavages and modifications of the pre-rRNA, or in the proper folding of rRNA prior to binding of ribosomal proteins. The roles of RNA helicases and RNA annealing proteins are well-established in the processing of pre-mRNA, but not in the processing of mammalian pre-rRNA. The long term objective of this proposed project is to do structural and functional characterizations of RH-II/Gu. The specific aims are (1) to do structural analyses of the RH-II/Gu protein including crystal structure of its RNA folding domain, (2) to determine the role(s) of RH-II/Gu protein in ribosomal RNA biogenesis, and (3) to examine structural features of the substrates recognized by RH-II/Gu. The results from this study will provide useful information on structural characterization and regulation of RH-II/Gu, and on the mechanism of mammalian rRNA production, a less characterized biochemical pathway compared to pre-mRNA splicing. RH-II/Gu may be an excellent chemotherapeutic target, and structural characterization of this enzyme may lead to drug development. This study may also provide an impetus for understanding the pathological roles of RH-II/Gu on the elicitation of autoimmune responses.
一个编码核仁RNA解旋酶的cDNA最近在我们的实验室中使用西瓜胃病患者的自身免疫血清进行了克隆。 我们实验室后来的研究表明,这种自身抗体也存在于一些结缔组织疾病患者中。 这种100-kDa的自身抗原,称为RH-II/Gu蛋白,是一种独特的双功能酶,具有5'至3' ATP依赖性RNA解旋活性和GTP刺激的RNA折叠/退火活性。 这两种活性受到相反的调节,并存在于同一多肽的不同结构域中。 这是第一个哺乳动物原型核仁RNA解旋酶被确定。 电子显微镜显示其定位于与rRNA的转录、早期加工和成熟相关的核仁结构。 据推测,RH-II/Gu参与rDNA转录、小核仁RNA的结合和/或解旋,其指导前rRNA的位点特异性切割和修饰,或在核糖体蛋白结合之前参与rRNA的正确折叠。 RNA解旋酶和RNA退火蛋白在前mRNA的加工中的作用是公认的,但在哺乳动物前rRNA的加工中没有。 本项目的长期目标是对RH-II/Gu进行结构和功能表征。 具体目的是(1)进行RH-II/Gu蛋白的结构分析,包括其RNA折叠结构域的晶体结构,(2)确定RH-II/Gu蛋白在核糖体RNA生物合成中的作用,和(3)检查RH-II/Gu识别的底物的结构特征。这项研究的结果将提供有用的信息结构表征和调节RH-II/Gu,和哺乳动物rRNA生产的机制,一个较少的生化途径相比,前mRNA剪接。 RH-II/Gu可能是一个很好的化疗靶点,这种酶的结构特征可能会导致药物开发。这项研究也可能为理解RH-II/Gu在引发自身免疫反应中的病理作用提供动力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENIGNO C VALDEZ其他文献
BENIGNO C VALDEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENIGNO C VALDEZ', 18)}}的其他基金
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 18.44万 - 项目类别:














{{item.name}}会员




